Find clinical trials for Heart Disease in Washington, DC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Heart Disease trials near Washington, DC, USA:
is intended to assess the ability of AZD3427 to reduce pulmonary vascular resistance (PVR) after 24 weeks of treatment in participants with heart...
Phase 2
Baltimore, Maryland, United States and 63 other locations
Cardiac catheterization with invasive coronary angiography is the gold standard for determining the presence or absence of significant coronary heart...
Baltimore, Maryland, United States
The objective of ENVISION is to evaluate the safety and effectiveness of the Navitor Transcatheter Aortic Valve Implantation (TAVI) System for treati...
Washington, District of Columbia, United States and 20 other locations
To collect information about treatment for severe aortic stenosis (AS), which affects the aortic valve in the heart. Aortic stenosis is a na...
Washington, District of Columbia, United States and 12 other locations
This study is testing a potential new medicine, NNC6019-0001, for people who have a heart disease due to TTR amyloidosis.The study ...
Phase 2
Baltimore, Maryland, United States and 30 other locations
The utility of Ultra High-Resolution Computed Tomography (UHR-CT) compared to conventional CT in all-comers (i.e., a generally lower-risk population)...
Baltimore, Maryland, United States
This study is comparing the use of Kcentra vs. standard transfusion in patients undergoing heart transplantation surgery. Half of the patien...
Phase 3
Baltimore, Maryland, United States and 2 other locations
Safety and performance evaluation of the preCARDIA System for patients with ADHF.
Washington, District of Columbia, United States and 16 other locations
The purpose of this study is to evaluate the device performance and monitor the safety and effectiveness of the Berlin Heart EXCOR Active Dr...
Washington, District of Columbia, United States and 10 other locations
This study will evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of PDE5, versus placebo...
Phase 3
Washington, District of Columbia, United States and 21 other locations
Clinical trials
Research sites
Resources
Legal